La Jolla Pharmaceutical owns latest Real Value of $15.8829 per share. The recent price of the firm is $10.31. At this time the firm appears to be undervalued. This module forecasts value of La Jolla Pharmaceutical from reviewing the firm fundamentals such as Return On Asset of
(40.87)%, Operating Margin of (816.09)% and Shares Owned by Institutions of 104.64% as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we recommend to invest in undervalued equities and to get rid of overvalued equities since at some future date instruments prices and their ongoing real values will come together.
August 24, 2019
La Jolla is slightly risky asset. Calculation of real value of La Jolla Pharmaceutical is based on 2 months time horizon. Increasing La Jolla Pharmaceutical time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
La Jolla Market CapLa Jolla Pharmaceutical Company is rated below average in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 4.6 Billion. La Jolla holds roughly 250.66 Million in market capitalization claiming about 5% of stocks in Biotechnology industry.
|Horizon||30 Days Login to change|
La Jolla Pharmaceutical Company is currently regarded as number one stock in beta category among related companies. It is rated below average in price to earning category among related companies .
|Price to Earning ( times )|